A detailed history of Firethorn Wealth Partners, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Firethorn Wealth Partners, LLC holds 11,700 shares of GLYC stock, worth $2,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,700
Holding current value
$2,574
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 10, 2025

BUY
$0.21 - $0.33 $2,457 - $3,861
11,700 New
11,700 $2,000

Others Institutions Holding GLYC

About GLYCOMIMETICS INC


  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $11.5M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Firethorn Wealth Partners, LLC Portfolio

Follow Firethorn Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.